Matches in Wikidata for { <http://www.wikidata.org/entity/Q98461674> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q98461674 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98461674 description "im Juli 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98461674 description "scientific article published on 01 July 2020" @default.
- Q98461674 description "wetenschappelijk artikel" @default.
- Q98461674 description "наукова стаття, опублікована 1 липня 2020" @default.
- Q98461674 name "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 name "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 type Item @default.
- Q98461674 label "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 label "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 prefLabel "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 prefLabel "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 P1433 Q98461674-BECC8653-9CDD-44BD-B9A5-BD6575D8B2E6 @default.
- Q98461674 P1476 Q98461674-AAAD0CAB-877A-439C-9BC6-E1B155A625F7 @default.
- Q98461674 P2093 Q98461674-002D8A89-21F5-44AD-BC10-5DAEC3BA81C2 @default.
- Q98461674 P2093 Q98461674-3888B1EB-3621-4BFA-8906-FDE2D06E9F70 @default.
- Q98461674 P2093 Q98461674-49183641-AC84-4B5D-9F03-7155828AA79A @default.
- Q98461674 P2093 Q98461674-7F0AB80C-5B23-4A97-9AD5-78B018F24602 @default.
- Q98461674 P2093 Q98461674-978471D5-783F-41D4-AB00-5B8A0ABB35C7 @default.
- Q98461674 P304 Q98461674-16B47B03-4E40-403D-B8E8-E3515468E8C3 @default.
- Q98461674 P31 Q98461674-F4A17E5C-6AB0-4378-96B9-9E91F22958C8 @default.
- Q98461674 P356 Q98461674-C4CC1F47-5B3D-4B86-B323-C79C55ADBF90 @default.
- Q98461674 P433 Q98461674-F15FCEA8-A90F-40FF-BEC1-D23819D28F22 @default.
- Q98461674 P478 Q98461674-BCFB1C64-141C-4C09-9BFE-A3B6DD20A411 @default.
- Q98461674 P577 Q98461674-699112DA-978C-4918-B4A8-0DE0F2E143DC @default.
- Q98461674 P698 Q98461674-6192B25F-F47A-4020-953A-5E920FCDF398 @default.
- Q98461674 P921 Q98461674-CD9FE417-309E-46E0-83AA-00690B6C1C47 @default.
- Q98461674 P356 CMA.J.CN501113-20191020-00385 @default.
- Q98461674 P698 32791800 @default.
- Q98461674 P1433 Q27714398 @default.
- Q98461674 P1476 "[Analysis of clinical efficacy, safety and prognosis of anlotinib hydrochloride in the treatment of advanced primary liver cancer]" @default.
- Q98461674 P2093 "M Song" @default.
- Q98461674 P2093 "S R Fan" @default.
- Q98461674 P2093 "X N Shi" @default.
- Q98461674 P2093 "Y M Wang" @default.
- Q98461674 P2093 "Y Meng" @default.
- Q98461674 P304 "619-624" @default.
- Q98461674 P31 Q13442814 @default.
- Q98461674 P356 "10.3760/CMA.J.CN501113-20191020-00385" @default.
- Q98461674 P433 "7" @default.
- Q98461674 P478 "28" @default.
- Q98461674 P577 "2020-07-01T00:00:00Z" @default.
- Q98461674 P698 "32791800" @default.
- Q98461674 P921 Q623031 @default.